568 related articles for article (PubMed ID: 31525954)
21. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
Hamad-Schifferli K
Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
[TBL] [Abstract][Full Text] [Related]
22. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
23. Protein-Nanoparticle Interactions: What Are the Protein-Corona Thickness and Organization?
Marichal L; Giraudon-Colas G; Cousin F; Thill A; Labarre J; Boulard Y; Aude JC; Pin S; Renault JP
Langmuir; 2019 Aug; 35(33):10831-10837. PubMed ID: 31333024
[TBL] [Abstract][Full Text] [Related]
24. Effects of Protein Source on Liposome Uptake by Cells: Corona Composition and Impact of the Excess Free Proteins.
Yang K; Reker-Smit C; Stuart MCA; Salvati A
Adv Healthc Mater; 2021 Jul; 10(14):e2100370. PubMed ID: 34050634
[TBL] [Abstract][Full Text] [Related]
25. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
26. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
27. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.
Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M
PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Uptake and Membrane Curvature Generation for the Internalization of Silica Nanoparticles by Cells.
Francia V; Reker-Smit C; Salvati A
Nano Lett; 2022 Apr; 22(7):3118-3124. PubMed ID: 35377663
[TBL] [Abstract][Full Text] [Related]
29. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
[TBL] [Abstract][Full Text] [Related]
30. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
31. Cell-Conditioned Protein Coronas on Engineered Particles Influence Immune Responses.
Dai Q; Guo J; Yan Y; Ang CS; Bertleff-Zieschang N; Caruso F
Biomacromolecules; 2017 Feb; 18(2):431-439. PubMed ID: 28075126
[TBL] [Abstract][Full Text] [Related]
32. Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells.
Aliyandi A; Reker-Smit C; Bron R; Zuhorn IS; Salvati A
ACS Biomater Sci Eng; 2021 Dec; 7(12):5573-5584. PubMed ID: 34761907
[TBL] [Abstract][Full Text] [Related]
33. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
34. Corona of Thorns: The Surface Chemistry-Mediated Protein Corona Perturbs the Recognition and Immune Response of Macrophages.
Cai R; Ren J; Ji Y; Wang Y; Liu Y; Chen Z; Farhadi Sabet Z; Wu X; Lynch I; Chen C
ACS Appl Mater Interfaces; 2020 Jan; 12(2):1997-2008. PubMed ID: 31867945
[TBL] [Abstract][Full Text] [Related]
35. Dual Functionalization of Nanoparticles for Generating Corona-Free and Noncytotoxic Silica Nanoparticles.
Affonso de Oliveira JF; Scheffer FR; Landis RF; Teixeira Neto É; Rotello VM; Cardoso MB
ACS Appl Mater Interfaces; 2018 Dec; 10(49):41917-41923. PubMed ID: 30426737
[TBL] [Abstract][Full Text] [Related]
36. In Situ Characterization of Protein Corona Formation on Silica Microparticles Using Confocal Laser Scanning Microscopy Combined with Microfluidics.
Weiss ACG; Krüger K; Besford QA; Schlenk M; Kempe K; Förster S; Caruso F
ACS Appl Mater Interfaces; 2019 Jan; 11(2):2459-2469. PubMed ID: 30600987
[TBL] [Abstract][Full Text] [Related]
37. The protein corona suppresses the cytotoxic and pro-inflammatory response in lung epithelial cells and macrophages upon exposure to nanosilica.
Leibe R; Hsiao IL; Fritsch-Decker S; Kielmeier U; Wagbo AM; Voss B; Schmidt A; Hessman SD; Duschl A; Oostingh GJ; Diabaté S; Weiss C
Arch Toxicol; 2019 Apr; 93(4):871-885. PubMed ID: 30838431
[TBL] [Abstract][Full Text] [Related]
38. Effect of endothelial cell heterogeneity on nanoparticle uptake.
Aliyandi A; Satchell S; Unger RE; Bartosch B; Parent R; Zuhorn IS; Salvati A
Int J Pharm; 2020 Sep; 587():119699. PubMed ID: 32736019
[TBL] [Abstract][Full Text] [Related]
39. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
40. On the formation of protein corona on colloidal nanoparticles stabilized by depletant polymers.
Petry R; Saboia VM; Franqui LS; Holanda CA; Garcia TRR; de Farias MA; de Souza Filho AG; Ferreira OP; Martinez DST; Paula AJ
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110080. PubMed ID: 31546390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
